This page shows the latest colorectal cancer news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca’s PD-L1 inhibitor Imfinzi and Bavarian Nordic’s cancer vaccine CV301 will be combined in a phase I/II trial involving patients with metastatic colorectal or pancreatic cancers. ... Colorectal and pancreatic cancers are among the most
market. Growth has also come from a steady stream of new indications, including recent approvals in hepatocellular carcinoma, renal cell carcinoma and colorectal cancer. ... stable trends”in second-line lung cancer in the US and good growth elsewhere
it has “several studies ongoing of rational combinations that include abemaciclib in non-small cell lung cancer and other malignancies”. ... It is nevertheless a setback to Lilly’s plans to develop the drug for specific tumour mutations such as KRAS
Germany and the UK will be the first to receive the skin cancer treatment. ... it introduced colorectal and head and neck cancer therapy Erbitux (cetuximab) more than a decade ago.
The green light is a big boost for the product which has been wrestling with tough competition in one of its other approved indications - colorectal cancer and gastrointestinal stromal tumours (GIST) - ... Meanwhile Bayer is also carrying out studies
The cancer drug has become the first to be approved by the FDA to treat all cancers with a specific tumour biomarker. ... BMS reported data last year showing that Opdivo was also effective in MSI-H colorectal cancer, both alone and in combination with
More from news
Approximately 18 fully matching, plus 225 partially matching documents found.
CAP7.1 prodrug of etoposide at start phase 3 for second line treatment of biliary tract cancer. ... Phase III toll-like receptor 9 agonist for metastatic colorectal cancer. 124.
data sources and the organisation of screening programmes for colorectal cancer. ... Cancer is an important disease to see [its] impact on the health system.
Dr Reddy's has expanded its collaboration with Amgen in India adding three approved products: Xgeva for treating bone metastases, Vectibix in colorectal cancer therapy and Prolia for osteoporosis. ... Janssen granted Tracon Pharmaceuticals the rights to
MK-3475 was awarded FDA breakthrough therapy status for advanced melanoma last year, and is being studied in 13 clinical trials across more than 30 types of cancer. ... BATON studies in colorectal cancer and metastatic triple negative breast cancer.
on the other side of the border, three tumours have comparable incidence rates, while colorectal cancer is a distant number four. ... Colorectal cancer. Colorectal cancer is where the two countries demonstrate the most substantial differences.
More from intelligence
Approximately 1 fully matching, plus 9 partially matching documents found.
On moving to the US in 2006, Dr Namouni took over responsibility for metastatic colorectal cancer treatment Erbitux (cetuximab), before serving as development lead for Opdivo (nivolumab) and Yervoy (ipilimumab).
colorectal cancer. ... Other recent additions include chief financial officeras chief medical officer; and several cancer experts to the company's scientific advisory board.
colorectal cancer.
Prior to this, he was director of clinical oncology at Bristol-Myers Squibb where he worked on the clinical development of Erbitux (cetuximab), which is approved for colorectal cancer and head ... This background will benefit Mirna, which has just
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
My grandfather was probably the first in the family to be afflicted with Lynch syndrome or Hereditary Nonpolyposis Colorectal Cancer (HNPCC). ... A revolutionary discovery. For my father, the cancer came back four more times.
Meanwhile two of the agency’ s campaigns for Sirtex - in collaboration with Denovo Strategy - in metastatic colorectal liver cancer are shortlisted, for Excellence in Media Relations and Excellence in Integrated
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
No results were found
Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...